04/26/2024 8:09 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024 6:57 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024 6:57 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024 5:25 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/19/2024 3:49 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) English Emily (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/12/2024 3:24 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
04/10/2024 8:47 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Singer Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
04/10/2024 8:35 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Jewell Christopher M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 8:40 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 8:43 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kalayoglu Murat (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 8:30 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kurtoglu Metin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 8:33 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Miljkovic Milos (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:20 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Hoge Elizabeth (Reporting) Seven One Eight Three Four Irrevocable Trust (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:25 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Singer Michael (Filed by)
| Form SC 13D/A | |
04/10/2024 3:29 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Kalayoglu Murat (Filed by)
| Form SC 13D/A | |
04/09/2024 6:00 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2024 3:32 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 4:27 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
03/26/2024 3:32 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 4:09 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 4:29 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 6:55 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 7:19 AM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
03/07/2024 6:06 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/07/2024 6:08 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/05/2024 6:05 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 4:27 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form DEFA14A | |
02/14/2024 3:42 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form DEF 14A | |
02/14/2024 11:38 AM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) MANGROVE PARTNERS IM, LLC (Filed by)
| Form SC 13G/A | |
02/09/2024 4:13 PM | Artal International S.C.A. (Filed by) Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 7:50 AM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G | |
01/31/2024 3:30 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form PRE 14A | |
01/23/2024 3:05 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K/A | |
01/08/2024 7:45 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 4:08 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Davis Blaine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 4:12 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Singer Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 3:39 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form D/A | |
12/03/2023 11:15 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form EFFECT | |
12/01/2023 3:43 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
12/01/2023 7:31 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form S-3/A | |
11/22/2023 3:38 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Kalayoglu Murat (Filed by)
| Form SC 13D | |
4 coins to be the “Next Bitcoin” (Ad) The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%...
Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 |
11/22/2023 3:39 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Singer Michael (Filed by)
| Form SC 13D | |
11/17/2023 8:51 AM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Hoge Elizabeth (Reporting) Seven One Eight Three Four Irrevocable Trust (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/17/2023 7:15 AM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
11/15/2023 4:26 PM | Brunn Carsten (Reporting) Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 4:26 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Davis Blaine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 4:14 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) COX CARRIE SMITH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 4:15 PM | BARABE TIMOTHY C (Reporting) Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 4:16 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Myers Scott Dunseth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 4:17 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Sallin Aymeric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 4:18 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) ZENNER PATRICK J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 4:18 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) DeSilva Nishan M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 4:20 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 3:40 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kurtoglu Metin (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/15/2023 3:40 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Miljkovic Milos (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 3:41 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kalayoglu Murat (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 3:41 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Singer Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 3:42 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Jewell Christopher M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 3:42 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kurtoglu Metin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 3:37 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Miljkovic Milos (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/15/2023 3:37 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kalayoglu Murat (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/15/2023 3:38 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Singer Michael (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/15/2023 3:38 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Jewell Christopher M (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/13/2023 3:31 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023 8:02 AM | SELECTA BIOSCIENCES INC (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 8:06 AM | SELECTA BIOSCIENCES INC (Filer) Cartesian Therapeutics (Filer)
| Form DEFA14A | |
10/25/2023 4:29 PM | SELECTA BIOSCIENCES INC (Filer) Cartesian Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
09/26/2023 5:00 PM | SELECTA BIOSCIENCES INC (Issuer) Cartesian Therapeutics (Issuer) TRABER PETER G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/26/2023 5:01 PM | Brunn Carsten (Reporting) SELECTA BIOSCIENCES INC (Issuer) Cartesian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 3:15 PM | SELECTA BIOSCIENCES INC (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/22/2023 6:31 PM | SELECTA BIOSCIENCES INC (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
09/13/2023 6:33 AM | SELECTA BIOSCIENCES INC (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/17/2023 6:10 AM | SELECTA BIOSCIENCES INC (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/17/2023 6:13 AM | SELECTA BIOSCIENCES INC (Filer) Cartesian Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/17/2023 6:13 AM | SELECTA BIOSCIENCES INC (Filer) Cartesian Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/17/2023 6:23 AM | SELECTA BIOSCIENCES INC (Filer) Cartesian Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/14/2023 6:00 AM | SELECTA BIOSCIENCES INC (Filer) Cartesian Therapeutics (Filer)
| Form NT 10-Q | |
06/16/2023 3:20 PM | SELECTA BIOSCIENCES INC (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2023 6:54 AM | SELECTA BIOSCIENCES INC (Filer) Cartesian Therapeutics (Filer)
| Form DEFA14A | |
06/01/2023 3:27 PM | Kishimoto Takashi Kei (Reporting) SELECTA BIOSCIENCES INC (Issuer) Cartesian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 6:35 AM | SELECTA BIOSCIENCES INC (Filer) Cartesian Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |